ALA vs DXB

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ALA

AROVELLA FPO [ALA]

37LOW

DXB

DIMERIX FPO [DXB]

37LOW

Score Breakdown

ALA DXB
Technical
48
51
Catalyst
53
58
Sentiment
50
50
Fundamental
57
82
Momentum
62
39
Risk Gate
46
50

Key Metrics

ALA Metric DXB
$82.1MMarket Cap$198.1M
604KAvg Volume (20d)1.2M
+0.1%Short Interest+0.1%
$0.12552-Week High$0.785
$0.06852-Week Low$0.310
+1.5%Daily Change+1.6%
$0.068Entry Price$0.325
-52.0%ROE-594.5%
-246.9%Profit Margin-219.9%

Active Signals

ALA Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (11 quarters)
●Revenue declining (-7%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Near 52-week low (0% of range)

DXB Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (4% of range)

Ask Scout AI to compare ALA and DXB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ALA Full Analysis → DXB Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).